» Articles » PMID: 22936421

Impaired Quality of Life in Patients in Long-term Remission of Cushing's Syndrome of Both Adrenal and Pituitary Origin: a Remaining Effect of Long-standing Hypercortisolism?

Overview
Specialty Endocrinology
Date 2012 Sep 1
PMID 22936421
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The determinants that cause impaired quality of life (QOL) in patients in long-term remission of Cushing's syndrome (CS) are unknown. The aim of this study was to get more insight into the patient and disease characteristics related to impaired QOL in these patients.

Design: Cross-sectional study.

Methods: The QOL of 123 patients in remission of CS (age 52.2 ± 12.0 years, 106 women, duration of remission 13.3 ± 10.4 years, 80% pituitary CS), assessed with seven validated questionnaires, was compared with the QOL of an age- and sex-matched control group (n=105). To investigate the influence of the aetiology of CS on QOL, patients in remission of pituitary and adrenal CS were compared. Furthermore, the influence of hormonal deficiencies, treatment strategy, duration of remission, gender and age on QOL was investigated.

Results: QOL in the total patient group and each patient subgroup was significantly worse on practically all dimensions of questionnaires compared with the control group (P<0.05), except for patients in remission of pituitary CS without hormonal deficiencies who had an impaired QOL on 50% of the QOL dimensions. Subgroup analysis revealed no difference in QOL between different patient groups, especially no difference between patients in remission of adrenal and pituitary CS. Female gender and a shorter duration of remission had a negative influence on QOL in the patient group.

Conclusions: QOL remains impaired in patients in long-term remission of CS regardless of aetiology, presence of hormonal deficiencies and treatment strategies. More research is needed to establish the causes.

Citing Articles

Brain Tumor at Diagnosis: From Cognition and Behavior to Quality of Life.

Chieffo D, Lino F, Ferrarese D, Belella D, Pepa G, Doglietto F Diagnostics (Basel). 2023; 13(3).

PMID: 36766646 PMC: 9914203. DOI: 10.3390/diagnostics13030541.


Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States.

Li D, Brand S, Hamidi O, Westfall A, Suresh M, Else T J Clin Endocrinol Metab. 2022; 107(7):e2851-e2861.

PMID: 35350067 PMC: 9202727. DOI: 10.1210/clinem/dgac175.


The quality of life in adult patients treated for Cushing's disease in childhood.

Pasternak-Pietrzak K, Moszczynska E, Szalecki M Pediatr Endocrinol Diabetes Metab. 2021; 27(2):93-99.

PMID: 34514766 PMC: 10214933. DOI: 10.5114/pedm.2021.107163.


Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome.

Acree R, Miller C, Abel B, Neary N, Campbell K, Nieman L J Endocr Soc. 2021; 5(8):bvab109.

PMID: 34195531 PMC: 8240411. DOI: 10.1210/jendso/bvab109.


Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study.

Bengtsson D, Ragnarsson O, Berinder K, Dahlqvist P, Engstrom B, Ekman B J Clin Endocrinol Metab. 2021; 106(6):1750-1760.

PMID: 33567076 PMC: 8118365. DOI: 10.1210/clinem/dgab079.